University Hospital, Akershus

This study tests whether adding an immunotherapy drug (nivolumab) to a standard chemotherapy (Nordic FLOX) can help control or shrink metastatic colorectal cancer that is mismatch repair proficient (pMMR) or microsatellite stable (MSS). These types usually don't respond well to i…

This study looks at whether certain proteins in the blood can tell if a person has blocked heart arteries, without needing a CT scan. About 1,000 adults with suspected heart disease will give blood samples and have a heart CT. The goal is to see if the blood test alone can accura…

This study looks at whether giving infliximab over 30 minutes is just as safe as the standard 60-minute infusion for children with inflammatory bowel disease (IBD). About 60 children aged 1-17 who have already had at least 5 infliximab infusions will receive 8 infusions, alternat…

This study looks at whether measuring certain heart-related substances in the blood early and giving that information to doctors can improve care for patients who are breathing fast. About 574 adults admitted to the hospital with a high breathing rate will be randomly assigned to…

This study follows 1,400 women who had a stroke with no clear cause. They received a small heart monitor implanted under the skin to check for hidden irregular heartbeats (atrial fibrillation) that can cause strokes. The goal is to see if finding and treating these heart issues w…

This study follows 450 people with gender incongruence who are starting or continuing gender-affirming hormone therapy. Researchers will use heart scans, blood tests, and quality-of-life surveys over time to see if the therapy has negative, neutral, or positive effects on the hea…